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Abstract 
Seborrheic dermatitis is an inflammatory eruption that tends to distribute on the sebaceous 
areas of the body and is rarely described as a paraneoplasia. Here we report a case with a 
responsive seborrheic dermatitis-like eruption of the head which resulted in generalized 
erythroderma. Intensive examinations detected concurrent malignant lymphoma. 
© 2014 S. Karger AG, Basel 
Case Report 
An 81-year-old woman recognized pruritic scaly erythemas on the scalp 2 months be-
fore the visit to our hospital. Her medical history included nephrosis syndrome that had 
been treated with oral cyclosporine 100 mg/day for 8 years. The results of routine blood 
work before the onset of skin eruptions had been normal. Although the head erythemas 
appeared to be seborrheic dermatitis (SD) [1], the lesions did not respond to topical 
steroidal lotion. When she visited our hospital, the eruption had disseminated to the trunk 
and extremities, resulting in generalized erythroderma (fig. 1). Laboratory tests showed 
white blood cells 13,900/μl (normal 3,500–9,800), hemoglobin 11.9 mg/dl (normal 11.3–
15.5), platelets 271,000/μl (normal 155,000–365,000), eosinophils 19.0%, atypical 
lymphocytes 2.0%, lactate dehydrogenase 517 IU/l (normal 176–353) and soluble 
interleukin-2 receptor 1,510 U/ml (normal <550); human T-lymphotropic virus type I 
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and eosinophils had infiltrated dominantly to the superficial perivascular space. There was 
no superficial dermal infiltrate of lymphocytes. A biopsy of her scalp lesion indicated only 
spongiotic dermatitis with parakeratosis. There was no atypical folliculotropic cell 
infiltration around follicles (fig. 2). Polymerase chain reaction and flow cytometry of the skin 
specimens failed to detect malignant cells. However, atypical lymphocytes (basket cells) 
were detected in the peripheral blood and bone marrow (fig. 3). Flow cytometry of the blood 
and bone marrow specimens showed that malignant cells were positive for CD2, CD3, CD4, 
CD5, CD7, CD25 and CD45RA. Positron emission tomography-computed tomography 
revealed abnormal enhancement of axillary and inguinal lymph nodes and bone marrow. We 
consulted a hematologist and peripheral T cell lymphoma not otherwise specified (PTCL-
NOS), stage IV according to Ann Arbor [2] was diagnosed. PTCL can cause SD-like dermatitis 
that gradually develops into auto-sensitization dermatitis. As chemotherapy was dismissed 
considering her age, we administered fexofenadine 120 mg/day and oral prednisolone 20 
mg/day so as to alleviate erythroderma and pruritus. Although most of the eruptions 
improved within a week, pruritus persisted. We added pregabalin 50 mg/day according to 
the recommendation by Yosipovitch [3], which reduced pruritus dramatically. The amount 
of daily oral steroid was tapered to 5 mg over 4 months, maintaining remission of cutaneous 
symptoms. 
Discussion 
Few publications have described SD as a paraneoplastic syndrome in cases with lung 
cancer and lymphoma [4–6]. The diagnosis of paraneoplastic syndrome usually requires 
concurrent onset and parallel course with malignancy at least. Although we could not 
confirm whether the severity of the SD would parallel that of PTCL, SD seems to be a 
paraneoplasia since the onset of the SD coincided with that of PTCL and the SD was resistant 
to ordinary topical therapy. 
Hematologic malignancies are often accompanied by severe pruritus. For chronic para-
neoplastic pruritus, antidepressant and anticonvulsive drugs such as gabapentin are 
anecdotally effective [3]. Although the mechanisms of pruritus as well as the antipruritic 
effect of anticonvulsive agents are not clear, they probably inhibit central itch pathways. We 
used low-dose pregabalin that worked and accelerated the improvement of SD. This may be 
an important option for severe paraneoplastic pruritus. 
In this case, simple SD and subsequent auto-sensitization dermatitis were suspected at 
first. However, the SD was too resistant to ordinal therapy and developed to erythroderma. 
Complete blood count revealed the presence of lymphoma that became an important clue to 
diagnosis. The differential diagnosis was folliculotropic mycosis fungoides. However, this 
possibility was ruled out by the results of pathological examinations. 
Disclosure Statement 
The authors report no conflicts of interest. There were no funding sources. 
References 
1 Burns T, Breathnach S, Cox N, Griffiths C (eds): Rook’s Textbook of Dermatology, ed 8. Oxford, Blackwell, 
















   
   
   
   
   
   
   
   
   
   
   
   



















 Case Rep Dermatol 2014;6:279–282 
DOI: 10.1159/000369991 
 
© 2014 S. Karger AG, Basel 
www.karger.com/cde 





2 Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana 
M: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: 
Cotswolds meeting. J Clin Oncol 1989;7:1630–1636. 
3 Yosipovitch G: Chronic pruritus: a paraneoplastic sign. Dermatol Ther 2010;23:590–596. 
4 Kokturk A, Ikizoglu G, Kaya TI, Baz K, Ulubas B, Apa DD: Seborrhoeic dermatitis-like manifestation of lung 
cancer evolving into erythrodermia. J Eur Acad Dermatol Venereol 2004;18:381–382. 
5 Venkateswaran S, Garg BR, Reddy BS, Narasimhan R: Cutaneous lymphoma mimicking seborrhoeic 
dermatitis. Indian J Dermatol Venereol Leprol 1995;61:45–47. 























   
   
   
   
   
   
   
   
   
   
   
   



















 Case Rep Dermatol 2014;6:279–282 
DOI: 10.1159/000369991 
 
© 2014 S. Karger AG, Basel 
www.karger.com/cde 






Fig. 2. There was no atypical folliculotropic cell infiltration around follicles. The biopsy of the scalp lesion 




Fig. 3. Atypical lymphocytes (basket cells) were detected in the peripheral blood and bone marrow. No 
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